Serum osteoprotegerin but not receptor activator of NF-κB ligand correlates with Larsen score in rheumatoid arthritis
Open Access
- 1 February 2004
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 63 (2) , 216-217
- https://doi.org/10.1136/ard.2002.004507
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Serum levels of osteoprotegerin increase with age in a healthy adult populationBone, 2003
- Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic jointRheumatology, 2001
- Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biologyJournal of Molecular Medicine, 2001
- Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependentThe Journal of Pathology, 2000
- Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2000
- Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factorArthritis & Rheumatism, 2000
- The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature OsteoclastsThe Journal of cell biology, 1999
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997